+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Binding interaction studies of selected receptor subpopulations after partial cross-linking receptor-ligand complexes with a photoactivated heterobifunctional reagent



Binding interaction studies of selected receptor subpopulations after partial cross-linking receptor-ligand complexes with a photoactivated heterobifunctional reagent



Journal of Clinical Investigation 78(1): 67-72



Certain hormonal and nonhormonal binding systems such as the leukoagglutinin-lymphocyte model exhibit complex receptor-ligand interactions that result in nonlinear Scatchard plots. Such plots are interpreted as indicating either homogeneous negatively interacting binding sites or heterogeneous sites with different and fixed affinity. We assessed the validity of these interpretations in our system by conjugating the ligand to a photoactivated heterobifunctional agent and cross-linking the conjugate to a subset of receptors before studying the binding interactions of non-cross-linked sites. Conjugation did not qualitatively or quantitatively affect the binding properties of the ligand. Cross-linking was specific, efficient, and stable and had no effect on irrelevant surface receptors. Cross-linking of only 3% of the total receptors resulted in 50% decreased ligand binding to high affinity sites consistent with a calculated inactivation of 85% and 2% of high and low affinity sites, respectively. Such preferential inactivation of high affinity sites in an unequivocal demonstration of binding sites heterogeneity in this system and shows a clear rejection of the homogeneous cooperation model.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039388128

Download citation: RISBibTeXText

PMID: 3522629


Related references

Synthesis and characterization of a heterobifunctional mercurial cross-linking agent: incorporation into cobratoxin and interaction with the nicotinic acetylcholine receptor. Biochemistry 30(29): 7231-7241, 1991

Photoactivated heterobifunctional cross-linking reagents which demonstrate the aggregation state of phospholipase A2. Biochemistry 16(25): 5650-5654, 1977

Photoactivated heterobifunctional cross-linking reagents which demonstrate the aggregation state of phospholipase A 2. Biochemistry 16(25): 5650-5654, 1977

Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies. Journal of Medicinal Chemistry 54(23): 8136-8147, 2011

Evidence for a ligand interaction site at the amino-terminus of the parathyroid hormone (PTH)/PTH-related protein receptor from cross-linking and mutational studies. Journal of Biological Chemistry 273(27): 16890-6, 1998

Analysis of protein ligand-receptor binding by photoaffinity cross-linking. Current Protocols in Protein Science 79: 19.26.1-19.26.14, 2015

Subunit interaction sites between the regulatory and catalytic subunits of cAMP-dependent protein kinase. Heterobifunctional cross-linking reagents lead to photodependent and photoindependent cross-linking. Journal of Biological Chemistry 263(11): 5170-5175, 1988

A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates. Analytical Biochemistry 194(1): 156-162, 1991

A novel biotinylated heterobifunctional cross-linking reagent bearing an aromatic diazirine. Bioorganic and Medicinal Chemistry 2(12): 1367-1373, 1994

Semi-reversible cross-linking. Synthesis and application of a novel heterobifunctional reagent. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 362(4): 421-428, 1981

AMPA receptor ligand binding domain mobility revealed by functional cross linking. Journal of Neuroscience 29(38): 11912-11923, 2009

Ligand binding regions in the receptor for urokinase-type plasminogen activator. Structural requirements for a multidomain binding region and receptor-receptor interaction. Journal of Biological Chemistry 276(31): 28946-28953, 2001

The use of in vitro peptide binding profiles and in silico ligand-receptor interaction profiles to describe ligand-induced conformations of the retinoid X receptor alpha ligand-binding domain. Molecular Endocrinology 21(1): 30-48, 2007

Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes. Molecular Endocrinology 4(2): 276-286, 1990

P-Azidophenylglyoxal. A heterobifunctional photoactivable cross-linking reagent selective for arginyl residues. Journal of Biological Chemistry 256(21): 11313-8, 1981